Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 7/20 | 0.43 |
| ▸ | HSD17B2 | P37059 | 6/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 3/20 | 0.38 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.36 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HTR1D | P28221 | 1/20 | 0.32 |
| ▸ | HTR1B | P28222 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6067774 | 0.71 | HSD17B1 (0.65) | HSD17B1HSD17B2CYP2A6PGR | |
| SCHEMBL21774309 | 0.71 | ERN1 (0.40) | HSD17B1HSD17B2CYP2A6PGRGRIN2B | |
| SCHEMBL9193008 | 0.69 | CYP2A6 (0.50) | HSD17B1HSD17B2CYP2A6PGRPDGFRB | |
| SCHEMBL15286618 | 0.69 | CYP2A6 (0.33) | HSD17B1HSD17B2CYP2A6 | |
| SCHEMBL15286929 | 0.68 | HSD17B1 (0.37) | HSD17B1HSD17B2CYP2A6PGRPDGFRB | |
| SCHEMBL30393125 | 0.67 | CYP2A6 (0.48) | HSD17B1HSD17B2CYP2A6PGRKDM4E | |
| SCHEMBL17514493 | 0.67 | CYP2A6 (0.74) | HSD17B1HSD17B2CYP2A6PDGFRBPDGFRA | |
| SCHEMBL6298604 | 0.67 | HSD17B1 (0.46) | HSD17B1HSD17B2CYP2A6PGRPDGFRB | |
| SCHEMBL9060576 | 0.67 | — | — | |
| SCHEMBL19953076 | 0.66 | AHR (0.50) | CYP2A6KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3843724-A1 | BENZIMIDAZOLE COMPOUNDS AND USE THEREOF FOR TREATING ALZHEIMER'S DISEASE OR HUNTINGTON'S DISEASE | National Health Research Institutes (TW) | 2021-07-07 | — | — | EP | disclosed |
| WO-2020047360-A1 | BENZIMIDAZOLE COMPOUNDS AND USE THEREOF FOR TREATING ALZHEIMER'S DISEASE OR HUNTINGTON'S DISEASE | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2020-03-05 | — | — | WO | disclosed |